Nasal universal vaccine in mice & Personalized mRNA vaccine for TNBC - News (Feb 20, 2026)
February 20, 202612m 2s
Audio is streamed directly from the publisher (mcdn.podbean.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Please support this podcast by checking out our sponsors:
- Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily
- Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad
- Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad
Support The Automated Daily directly:
Buy me a coffee: https://buymeacoffee.com/theautomateddaily
Today's topics: Nasal universal vaccine in mice - A Stanford-led *Science* study reports a nasal “universal vaccine” that boosted innate immunity in mice, protecting against SARS‑CoV‑2, other coronaviruses, bacteria, and even allergic asthma—raising big questions about human safety and efficacy. Personalized mRNA vaccine for TNBC - A *Nature* paper from the TNBC‑MERIT phase 1 trial shows an individualized neoantigen mRNA vaccine (RNA–LPX) is feasible after surgery and standard therapy in early triple-negative breast cancer, producing durable multi-epitope T‑cell responses with manageable reactogenicity. Kenya rolls out lenacapavir PrEP - Kenya plans an early-March rollout of lenacapavir, a twice‑yearly injectable HIV prevention drug shown to cut transmission risk by more than 99.9%, amid shifting global health funding and continued high HIV burden in eastern and southern Africa. India’s AI summit and investments - At the India AI Impact Summit in New Delhi, Prime Minister Narendra Modi pitched India as a global AI hub, with major commitments from Microsoft, Google, and Amazon and calls for “inclusive, multilingual” AI alongside Global South capacity-building proposals. Pax Silica semiconductor partnership - India joined Pax Silica, a U.S.-led framework to strengthen semiconductor and critical-tech supply chains, reflecting deeper U.S.–India strategic alignment and efforts to reduce reliance on China-dominated manufacturing ecosystems. Social media lawsuits over child safety - Meta, TikTok, and others face expanding U.S. litigation alleging addictive design and failures to protect children from harmful content and predators, with jury trials and bellwether cases testing First Amendment and Section 230 defenses. UK 48-hour takedown law - The UK government proposes a rule forcing platforms to remove non-consensual intimate images within 48 hours, with steep fines up to 10% of global revenue and stronger re-upload prevention—treating the abuse like terrorist and child sexual abuse content. Sudan Darfur violence genocide warning - U.N.-backed experts say RSF actions around el‑Fasher in Darfur show “hallmarks of genocide,” citing mass killings, sexual violence, siege conditions, and ethnically targeted attacks—fueling calls for accountability and civilian protection. AI music tools from Google Apple - Google and Apple are mainstreaming generative AI in music: Gemini can create short tracks with DeepMind’s Lyria 3, while Apple Music’s “Playlist Playground” turns prompts into playlists—intensifying copyright, rights, and industry disruption debates. Cat cancer genome map insights - A large feline cancer genomics project sequenced 493 cat tumors and found human-like driver mutations—especially TP53 and breast-cancer-linked FBXW7—supporting “One Health” research and precision oncology across species.
Episode Transcript
Nasal universal vaccine in mice
Let’s start with that surprising vaccine research. A Stanford-led team, publishing in *Science* on February 19th, reports a nasally delivered “universal vaccine” concept that protected mice for at least three months against a range of respiratory threats—SARS‑CoV‑2 and other coronaviruses, plus bacteria that can trigger serious lung infections. What’s different here is the target: instead of teaching the adaptive immune system to recognize one pathogen, the formulation “supercharges” innate immunity—those early, broad defenses your body uses before it knows exactly what it’s fighting.
The vaccine combines two drugs that activate receptors on innate immune cells in the lungs, alongside a third component designed to keep that activation from fading. That sustaining piece also triggered a T‑cell population and used an immunogenic protein derived from chicken eggs; when researchers left it out, protection dropped off quickly. In these mouse experiments, four nasal doses didn’t just blunt infections—they also reduced allergic hypersensitivity to dust mites, preventing allergic-asthma-like symptoms. The proposed mechanism is a “two-bulwark” setup: strengthen the mucosal barrier to limit entry, then accelerate lung immune responses to clear what gets through. Outside experts called the data compelling, with the big caveat that safety and real-world performance in humans remain unknown.
Personalized mRNA vaccine for TNBC
Staying in medical research, a *Nature* paper is out with detailed results from the individualized neoantigen mRNA vaccine arm of TNBC‑MERIT—an early, first-in-human phase 1 umbrella trial in early-stage triple-negative breast cancer after surgery and standard (neo)adjuvant treatment.
Here, the approach was highly personalized: each patient’s tumor was sequenced, and up to 20 tumor-specific mutations were selected as neoantigen targets. Those targets were encoded on two mRNAs and delivered intravenously via lipid nanoparticles designed to reach dendritic cells—key orchestrators of T-cell immunity.
Fifteen patients consented; 14 received vaccination per protocol and were evaluable. Manufacturing was “on-demand” and, importantly, workable in routine clinical settings, with an average turnaround of about 69 days from sample receipt to vaccine release. Side effects were mainly short-lived flu-like reactogenicity—fever, chills, fatigue—mostly grade 1 to 2, with one patient discontinuing after hypotension and other symptoms.
On immune readouts, all 14 patients showed vaccine-induced or vaccine-amplified T-cell responses to at least one neoantigen target, sometimes several. Many responses were multi-epitope, and most immunogenic epitopes skewed CD4-positive, though CD8 responses were also observed, including persistent neoantigen-specific CD8 T cells detectable years later in some cases. Clinically, and with the usual caution for a small, uncontrolled phase 1 study, most patients remained relapse-free at long follow-up, while recurrence analyses suggested different escape routes—like weaker initial immunogenicity, loss of antigen presentation machinery, or a recurrence arising from a genetically distinct tumor not used for vaccine design. The authors frame this as a feasibility-and-immunogenicity win that now needs controlled testing.
Kenya rolls out lenacapavir PrEP
One more major health story, this time in public health implementation: Kenya’s health ministry says it will begin rolling out lenacapavir for HIV prevention in early March across 15 priority regions. It’s a twice-yearly injection with reported risk reduction above 99.9% in studies—often described as game-changing, even though it’s not a vaccine in the classic sense because it doesn’t train the immune system.
Kenya received an initial shipment of 21,000 doses through an arrangement involving Gilead Sciences and the Global Fund, with more continuation doses expected soon and additional supply commitments from the U.S. The rollout lands in a complicated funding environment, with broader disruption to HIV programs after U.S. aid cuts—yet Kenya and the U.S. also signed a sizable multi-year health aid agreement in December that includes HIV priorities. The big practical question now is pace and coverage: getting a highly effective tool into the communities that need it, consistently, over time.
India’s AI summit and investments
Turning to technology and geopolitics, India used this week’s India AI Impact Summit in New Delhi to make a clear pitch: build in India, scale to the world. Prime Minister Narendra Modi framed the country as a cost-effective AI hub powered by its experience rolling out digital public infrastructure—think national digital ID and real-time payments.
The summit drew heavyweight voices, including French President Emmanuel Macron, Google CEO Sundar Pichai, and U.N. Secretary-General António Guterres. Guterres called for a $3 billion fund to help lower-income countries build baseline AI capacity—skills training, data access, and affordable computing—warning that the technology’s direction shouldn’t be set by a narrow club of nations or wealthy insiders.
India’s market size is part of the magnet: nearly a billion internet users. Major investment plans were highlighted, including Microsoft’s $17.5 billion over four years, Google’s $15 billion over five years—plus its first AI hub in India—and Amazon’s $35 billion pledge by 2030 tied to AI-driven digitization. OpenAI CEO Sam Altman also said OpenAI will collaborate with India’s Tata Group on AI initiatives, including data-center infrastructure. India, meanwhile, is still chasing a homegrown, globally leading large-scale model, with constraints that include access to advanced chips, data centers, and the sheer complexity of hundreds of languages.
And yes, the summit had some messy headlines: disruptions, long lines, reports of theft later said to be resolved, and the expulsion of a private university after it showcased a commercially available Chinese-made robotic dog while presenting it as original innovation. Microsoft co-founder Bill Gates also withdrew from a scheduled keynote, with the Gates Foundation saying it was meant to keep focus on summit priorities amid renewed attention to Gates’ past ties to Jeffrey Epstein.
Pax Silica semiconductor partnership
Alongside that AI diplomacy, India also joined Pax Silica, a U.S.-led initiative meant to tighten tech cooperation and secure supply chains among strategic partners. The focus is semiconductors and advanced manufacturing—essentially, the plumbing of modern AI and electronics.
U.S. officials described the goal as reducing reliance on China-dominated manufacturing hubs and expanding “trusted” production networks, with other participants including Japan, South Korea, the UK, and Israel. The timing is notable: it follows a recent interim U.S.–India trade framework aimed at cutting tariffs and improving market access, and it underscores a warming alignment after a period of friction tied to India’s purchases of discounted Russian oil. Whatever the politics, the industrial reality is straightforward: chips and capacity are power, and countries are building blocs to secure both.
Social media lawsuits over child safety
Now to the growing legal pushback against social media platforms in the United States. Meta and TikTok—among others—are facing an expanding wave of lawsuits alleging they use addictive design features that harm children’s mental health and don’t do enough to protect kids from predators and dangerous content. After years of investigation and skepticism about whether these cases would actually reach juries, that’s changing.
Trials are underway in Los Angeles and New Mexico, with larger bellwether proceedings ahead—including a key multidistrict case scheduled for summer in Oakland involving public school districts. In Los Angeles, a bellwether trial centers on a 20-year-old plaintiff known as “KGM,” with Meta and YouTube as remaining defendants. Mark Zuckerberg testified, pointing to age limits and detection efforts for underage users, while rejecting the premise that addiction applies to Meta’s products.
New Mexico’s attorney general is pressing claims supported by undercover investigations where agents posed as minors and recorded solicitations and platform responses. The lawsuits are likely to test where legal shields like Section 230 and First Amendment defenses begin and end—potentially shaping not just payouts, but platform design, recommendation algorithms, and age verification in the years ahead.
UK 48-hour takedown law
Across the Atlantic, the UK is moving on a related—though distinct—digital safety front. The government is proposing a new legal duty that would require platforms to remove intimate images shared without consent within 48 hours. The plan would also require platforms to prevent re-uploads, so victims don’t have to keep filing reports as content resurfaces.
The proposed enforcement teeth are substantial: fines up to 10% of global sales, and the possibility of blocking services that don’t comply in the UK. The policy is being introduced as an amendment to the Crime and Policing Bill now moving through the House of Lords, and it comes after earlier legislation making non-consensual deepfake intimate images illegal. The message is clear: the government wants responsibility to sit more heavily with platforms, not individuals left to play endless cleanup.
Sudan Darfur violence genocide warning
To global affairs, the U.N.-backed fact-finding mission on Sudan is issuing one of its starkest assessments yet. Investigators say an October “campaign of destruction” by Sudan’s Rapid Support Forces—around el‑Fasher in Darfur—shows “hallmarks of genocide” against non-Arab communities, especially the Zaghawa and Fur.
According to the report, after an 18-month siege, the RSF imposed conditions described as calculated to bring about physical destruction, followed by the city’s fall on October 26th. U.N. officials cited several thousand civilians killed during the takeover and warned that only about 40% of roughly 260,000 residents may have escaped. The report details mass killings, summary executions, sexual violence, torture, and ransom abductions, and it argues multiple criteria of the Genocide Convention were met.
The RSF has previously acknowledged abuses while disputing scale. Investigators are urging accountability and stronger civilian protection, while the conflict—now nearing three years—continues to spread and deepen one of the world’s most severe humanitarian crises.
AI music tools from Google Apple
Finally, a quick look at how generative AI is landing in everyday entertainment. Google says its Gemini assistant can now generate 30-second music tracks from text prompts, images, or uploaded video using DeepMind’s Lyria 3 model, with options for lyrics or instrumentals and AI-generated cover art. Apple, meanwhile, announced “Playlist Playground” in Apple Music, using Apple Intelligence to turn prompts into playlists complete with cover art and descriptions.
Both releases underline the same tension: these tools are getting easier and more mainstream, while the music industry keeps pressing hard questions about copyright, training data, and whether AI outputs can imitate artists too closely. Google says it’s using filters to avoid IP and privacy violations and claims it trains on music it has rights to use through a mix of terms, partner agreements, and applicable law. Expect this category to move quickly—and expect the policy debates to move slowly.
And one more science note worth your time: a large-scale *Science* study has produced a genetic map of feline cancers by sequencing 493 cat tumors across 13 cancer types. The striking takeaway is how often the same kinds of driver mutations show up in cats and humans—TP53 leading the list—and how closely feline mammary tumors can mirror certain human breast cancers, including changes in FBXW7 that are linked to prognosis. The dataset is now public, aiming to accelerate “One Health” research that benefits both veterinary and human oncology.
Subscribe to edition specific feeds:
- Space news
* Apple Podcast English
* Spotify English
* RSS English Spanish French
- Top news
* Apple Podcast English Spanish French
* Spotify English Spanish French
* RSS English Spanish French
- Tech news
* Apple Podcast English Spanish French
* Spotify English Spanish Spanish
* RSS English Spanish French
- Hacker news
* Apple Podcast English Spanish French
* Spotify English Spanish French
* RSS English Spanish French
- AI news
* Apple Podcast English Spanish French
* Spotify English Spanish French
* RSS English Spanish French
Visit our website at https://theautomateddaily.com/
Send feedback to [email protected]
Youtube
LinkedIn
X (Twitter)
- Consensus: AI for Research. Get a free month - https://get.consensus.app/automated_daily
- Effortless AI design for presentations, websites, and more with Gamma - https://try.gamma.app/tad
- Discover the Future of AI Audio with ElevenLabs - https://try.elevenlabs.io/tad
Support The Automated Daily directly:
Buy me a coffee: https://buymeacoffee.com/theautomateddaily
Today's topics: Nasal universal vaccine in mice - A Stanford-led *Science* study reports a nasal “universal vaccine” that boosted innate immunity in mice, protecting against SARS‑CoV‑2, other coronaviruses, bacteria, and even allergic asthma—raising big questions about human safety and efficacy. Personalized mRNA vaccine for TNBC - A *Nature* paper from the TNBC‑MERIT phase 1 trial shows an individualized neoantigen mRNA vaccine (RNA–LPX) is feasible after surgery and standard therapy in early triple-negative breast cancer, producing durable multi-epitope T‑cell responses with manageable reactogenicity. Kenya rolls out lenacapavir PrEP - Kenya plans an early-March rollout of lenacapavir, a twice‑yearly injectable HIV prevention drug shown to cut transmission risk by more than 99.9%, amid shifting global health funding and continued high HIV burden in eastern and southern Africa. India’s AI summit and investments - At the India AI Impact Summit in New Delhi, Prime Minister Narendra Modi pitched India as a global AI hub, with major commitments from Microsoft, Google, and Amazon and calls for “inclusive, multilingual” AI alongside Global South capacity-building proposals. Pax Silica semiconductor partnership - India joined Pax Silica, a U.S.-led framework to strengthen semiconductor and critical-tech supply chains, reflecting deeper U.S.–India strategic alignment and efforts to reduce reliance on China-dominated manufacturing ecosystems. Social media lawsuits over child safety - Meta, TikTok, and others face expanding U.S. litigation alleging addictive design and failures to protect children from harmful content and predators, with jury trials and bellwether cases testing First Amendment and Section 230 defenses. UK 48-hour takedown law - The UK government proposes a rule forcing platforms to remove non-consensual intimate images within 48 hours, with steep fines up to 10% of global revenue and stronger re-upload prevention—treating the abuse like terrorist and child sexual abuse content. Sudan Darfur violence genocide warning - U.N.-backed experts say RSF actions around el‑Fasher in Darfur show “hallmarks of genocide,” citing mass killings, sexual violence, siege conditions, and ethnically targeted attacks—fueling calls for accountability and civilian protection. AI music tools from Google Apple - Google and Apple are mainstreaming generative AI in music: Gemini can create short tracks with DeepMind’s Lyria 3, while Apple Music’s “Playlist Playground” turns prompts into playlists—intensifying copyright, rights, and industry disruption debates. Cat cancer genome map insights - A large feline cancer genomics project sequenced 493 cat tumors and found human-like driver mutations—especially TP53 and breast-cancer-linked FBXW7—supporting “One Health” research and precision oncology across species.
Episode Transcript
Nasal universal vaccine in mice
Let’s start with that surprising vaccine research. A Stanford-led team, publishing in *Science* on February 19th, reports a nasally delivered “universal vaccine” concept that protected mice for at least three months against a range of respiratory threats—SARS‑CoV‑2 and other coronaviruses, plus bacteria that can trigger serious lung infections. What’s different here is the target: instead of teaching the adaptive immune system to recognize one pathogen, the formulation “supercharges” innate immunity—those early, broad defenses your body uses before it knows exactly what it’s fighting.
The vaccine combines two drugs that activate receptors on innate immune cells in the lungs, alongside a third component designed to keep that activation from fading. That sustaining piece also triggered a T‑cell population and used an immunogenic protein derived from chicken eggs; when researchers left it out, protection dropped off quickly. In these mouse experiments, four nasal doses didn’t just blunt infections—they also reduced allergic hypersensitivity to dust mites, preventing allergic-asthma-like symptoms. The proposed mechanism is a “two-bulwark” setup: strengthen the mucosal barrier to limit entry, then accelerate lung immune responses to clear what gets through. Outside experts called the data compelling, with the big caveat that safety and real-world performance in humans remain unknown.
Personalized mRNA vaccine for TNBC
Staying in medical research, a *Nature* paper is out with detailed results from the individualized neoantigen mRNA vaccine arm of TNBC‑MERIT—an early, first-in-human phase 1 umbrella trial in early-stage triple-negative breast cancer after surgery and standard (neo)adjuvant treatment.
Here, the approach was highly personalized: each patient’s tumor was sequenced, and up to 20 tumor-specific mutations were selected as neoantigen targets. Those targets were encoded on two mRNAs and delivered intravenously via lipid nanoparticles designed to reach dendritic cells—key orchestrators of T-cell immunity.
Fifteen patients consented; 14 received vaccination per protocol and were evaluable. Manufacturing was “on-demand” and, importantly, workable in routine clinical settings, with an average turnaround of about 69 days from sample receipt to vaccine release. Side effects were mainly short-lived flu-like reactogenicity—fever, chills, fatigue—mostly grade 1 to 2, with one patient discontinuing after hypotension and other symptoms.
On immune readouts, all 14 patients showed vaccine-induced or vaccine-amplified T-cell responses to at least one neoantigen target, sometimes several. Many responses were multi-epitope, and most immunogenic epitopes skewed CD4-positive, though CD8 responses were also observed, including persistent neoantigen-specific CD8 T cells detectable years later in some cases. Clinically, and with the usual caution for a small, uncontrolled phase 1 study, most patients remained relapse-free at long follow-up, while recurrence analyses suggested different escape routes—like weaker initial immunogenicity, loss of antigen presentation machinery, or a recurrence arising from a genetically distinct tumor not used for vaccine design. The authors frame this as a feasibility-and-immunogenicity win that now needs controlled testing.
Kenya rolls out lenacapavir PrEP
One more major health story, this time in public health implementation: Kenya’s health ministry says it will begin rolling out lenacapavir for HIV prevention in early March across 15 priority regions. It’s a twice-yearly injection with reported risk reduction above 99.9% in studies—often described as game-changing, even though it’s not a vaccine in the classic sense because it doesn’t train the immune system.
Kenya received an initial shipment of 21,000 doses through an arrangement involving Gilead Sciences and the Global Fund, with more continuation doses expected soon and additional supply commitments from the U.S. The rollout lands in a complicated funding environment, with broader disruption to HIV programs after U.S. aid cuts—yet Kenya and the U.S. also signed a sizable multi-year health aid agreement in December that includes HIV priorities. The big practical question now is pace and coverage: getting a highly effective tool into the communities that need it, consistently, over time.
India’s AI summit and investments
Turning to technology and geopolitics, India used this week’s India AI Impact Summit in New Delhi to make a clear pitch: build in India, scale to the world. Prime Minister Narendra Modi framed the country as a cost-effective AI hub powered by its experience rolling out digital public infrastructure—think national digital ID and real-time payments.
The summit drew heavyweight voices, including French President Emmanuel Macron, Google CEO Sundar Pichai, and U.N. Secretary-General António Guterres. Guterres called for a $3 billion fund to help lower-income countries build baseline AI capacity—skills training, data access, and affordable computing—warning that the technology’s direction shouldn’t be set by a narrow club of nations or wealthy insiders.
India’s market size is part of the magnet: nearly a billion internet users. Major investment plans were highlighted, including Microsoft’s $17.5 billion over four years, Google’s $15 billion over five years—plus its first AI hub in India—and Amazon’s $35 billion pledge by 2030 tied to AI-driven digitization. OpenAI CEO Sam Altman also said OpenAI will collaborate with India’s Tata Group on AI initiatives, including data-center infrastructure. India, meanwhile, is still chasing a homegrown, globally leading large-scale model, with constraints that include access to advanced chips, data centers, and the sheer complexity of hundreds of languages.
And yes, the summit had some messy headlines: disruptions, long lines, reports of theft later said to be resolved, and the expulsion of a private university after it showcased a commercially available Chinese-made robotic dog while presenting it as original innovation. Microsoft co-founder Bill Gates also withdrew from a scheduled keynote, with the Gates Foundation saying it was meant to keep focus on summit priorities amid renewed attention to Gates’ past ties to Jeffrey Epstein.
Pax Silica semiconductor partnership
Alongside that AI diplomacy, India also joined Pax Silica, a U.S.-led initiative meant to tighten tech cooperation and secure supply chains among strategic partners. The focus is semiconductors and advanced manufacturing—essentially, the plumbing of modern AI and electronics.
U.S. officials described the goal as reducing reliance on China-dominated manufacturing hubs and expanding “trusted” production networks, with other participants including Japan, South Korea, the UK, and Israel. The timing is notable: it follows a recent interim U.S.–India trade framework aimed at cutting tariffs and improving market access, and it underscores a warming alignment after a period of friction tied to India’s purchases of discounted Russian oil. Whatever the politics, the industrial reality is straightforward: chips and capacity are power, and countries are building blocs to secure both.
Social media lawsuits over child safety
Now to the growing legal pushback against social media platforms in the United States. Meta and TikTok—among others—are facing an expanding wave of lawsuits alleging they use addictive design features that harm children’s mental health and don’t do enough to protect kids from predators and dangerous content. After years of investigation and skepticism about whether these cases would actually reach juries, that’s changing.
Trials are underway in Los Angeles and New Mexico, with larger bellwether proceedings ahead—including a key multidistrict case scheduled for summer in Oakland involving public school districts. In Los Angeles, a bellwether trial centers on a 20-year-old plaintiff known as “KGM,” with Meta and YouTube as remaining defendants. Mark Zuckerberg testified, pointing to age limits and detection efforts for underage users, while rejecting the premise that addiction applies to Meta’s products.
New Mexico’s attorney general is pressing claims supported by undercover investigations where agents posed as minors and recorded solicitations and platform responses. The lawsuits are likely to test where legal shields like Section 230 and First Amendment defenses begin and end—potentially shaping not just payouts, but platform design, recommendation algorithms, and age verification in the years ahead.
UK 48-hour takedown law
Across the Atlantic, the UK is moving on a related—though distinct—digital safety front. The government is proposing a new legal duty that would require platforms to remove intimate images shared without consent within 48 hours. The plan would also require platforms to prevent re-uploads, so victims don’t have to keep filing reports as content resurfaces.
The proposed enforcement teeth are substantial: fines up to 10% of global sales, and the possibility of blocking services that don’t comply in the UK. The policy is being introduced as an amendment to the Crime and Policing Bill now moving through the House of Lords, and it comes after earlier legislation making non-consensual deepfake intimate images illegal. The message is clear: the government wants responsibility to sit more heavily with platforms, not individuals left to play endless cleanup.
Sudan Darfur violence genocide warning
To global affairs, the U.N.-backed fact-finding mission on Sudan is issuing one of its starkest assessments yet. Investigators say an October “campaign of destruction” by Sudan’s Rapid Support Forces—around el‑Fasher in Darfur—shows “hallmarks of genocide” against non-Arab communities, especially the Zaghawa and Fur.
According to the report, after an 18-month siege, the RSF imposed conditions described as calculated to bring about physical destruction, followed by the city’s fall on October 26th. U.N. officials cited several thousand civilians killed during the takeover and warned that only about 40% of roughly 260,000 residents may have escaped. The report details mass killings, summary executions, sexual violence, torture, and ransom abductions, and it argues multiple criteria of the Genocide Convention were met.
The RSF has previously acknowledged abuses while disputing scale. Investigators are urging accountability and stronger civilian protection, while the conflict—now nearing three years—continues to spread and deepen one of the world’s most severe humanitarian crises.
AI music tools from Google Apple
Finally, a quick look at how generative AI is landing in everyday entertainment. Google says its Gemini assistant can now generate 30-second music tracks from text prompts, images, or uploaded video using DeepMind’s Lyria 3 model, with options for lyrics or instrumentals and AI-generated cover art. Apple, meanwhile, announced “Playlist Playground” in Apple Music, using Apple Intelligence to turn prompts into playlists complete with cover art and descriptions.
Both releases underline the same tension: these tools are getting easier and more mainstream, while the music industry keeps pressing hard questions about copyright, training data, and whether AI outputs can imitate artists too closely. Google says it’s using filters to avoid IP and privacy violations and claims it trains on music it has rights to use through a mix of terms, partner agreements, and applicable law. Expect this category to move quickly—and expect the policy debates to move slowly.
And one more science note worth your time: a large-scale *Science* study has produced a genetic map of feline cancers by sequencing 493 cat tumors across 13 cancer types. The striking takeaway is how often the same kinds of driver mutations show up in cats and humans—TP53 leading the list—and how closely feline mammary tumors can mirror certain human breast cancers, including changes in FBXW7 that are linked to prognosis. The dataset is now public, aiming to accelerate “One Health” research that benefits both veterinary and human oncology.
Subscribe to edition specific feeds:
- Space news
* Apple Podcast English
* Spotify English
* RSS English Spanish French
- Top news
* Apple Podcast English Spanish French
* Spotify English Spanish French
* RSS English Spanish French
- Tech news
* Apple Podcast English Spanish French
* Spotify English Spanish Spanish
* RSS English Spanish French
- Hacker news
* Apple Podcast English Spanish French
* Spotify English Spanish French
* RSS English Spanish French
- AI news
* Apple Podcast English Spanish French
* Spotify English Spanish French
* RSS English Spanish French
Visit our website at https://theautomateddaily.com/
Send feedback to [email protected]
Youtube
X (Twitter)